Protease-activated receptor PAR4 drives cardiac inflammatin in diabetes

被引：0
|
作者：
Fender, A. [1 ]
Stolte, S. [1 ]
Leineweber, K. [1 ]
Kamler, M. [2 ]
Dobrev, D. [1 ]
机构：
[1] Univ Duisburg Essen, Inst Pharmacol, Fac Med, Essen, Germany
[2] Univ Duisburg Essen, Dept Thorac & Cardiovasc Surg, Fac Med, Essen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2020年 / 393卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
46
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [41] Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets
    Duvernay, Matthew T.
    Temple, Kayla J.
    Maeng, Jae G.
    Blobaum, Anna L.
    Stauffer, Shaun R.
    Lindsley, Craig W.
    Hamm, Heidi E.
    MOLECULAR PHARMACOLOGY, 2017, 91 (01) : 39 - 47
  • [42] Improved Inhibition of Protease-Activated Receptor 4 (PAR4) with Function-Blocking Antibodies Provides Equivalent Antithrombotic Activity in the Face of the Hyper-Reactive Thr120 PAR4 Variant
    French, Shauna L.
    Thalmann, Claudia
    Machlus, Kellie
    Sleeman, Mark A.
    Hamilton, Justin R.
    BLOOD, 2017, 130
  • [43] Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR1 and PAR4 in platelets
    Navarro-Nunez, L.
    Rivera, J.
    Guerrero, J. A.
    Martinez, C.
    Vicente, V.
    Lozano, M. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (06) : 1548 - 1556
  • [44] Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4
    Bah, Alaji
    Chen, Zhiwei
    Bush-Pec, Leslie A.
    Mathews, F. Scott
    Di Cera, Enrico
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (28) : 11603 - 11608
  • [45] Quantitative Phosphoproteomics And Causal Analysis Reveal Distinct And Combinatorial Signaling Mechanisms In Protease-Activated Receptor PAR1 And PAR4 Platelet Activation Programs
    Reitsma, Stephanie
    Klimek, John
    Parra-Izquierdo, Ivan
    Babur, Ozgun
    Melrose, Alexander
    Zheng, Tony
    Pang, Jiaqing
    McCarty, Owen J.
    Minnier, Jessica
    Wilmarth, Phillip
    Demir, Emek
    Reddy, Ashok
    David, Larry
    Aslan, Joseph
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41
  • [46] Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets (vol 83, pg 781, 2013)
    Duvernay, M.
    Young, S.
    Gailani, D.
    Schoenecker, J.
    Hamm, Heidi E.
    MOLECULAR PHARMACOLOGY, 2013, 84 (03) : 487 - 487
  • [47] Mapping the Interface Between Protease Activated Receptor 1 (PAR1) and PAR4 Heterodimers.
    Noble, Daniel N.
    de la Fuente, Maria
    Nieman, Marvin T.
    BLOOD, 2010, 116 (21) : 1312 - 1312
  • [48] PAR-4-The PARagon of protease-activated receptors?
    Geisler, Tobias
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 252 : 167 - 168
  • [49] Exploring the structural basis of protease activated receptor 4 (PAR4) protein interactions by proteomic analysis
    Bonfanti, Marco
    Van Den Driest, Lisa
    Gould, Gwyn
    Cunningham, Margaret Rose
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (04) : 482 - 482
  • [50] Agonists of protease-activated receptors (PAR1, PAR2 and PAR4) do not appear to be mediators of NANC contractions in rat bladder
    Long, JM
    Kaefer, M
    Packer, CS
    FASEB JOURNAL, 2004, 18 (05): : A1083 - A1083
12345